Vaxart, Inc.
VXRT
$0.68
$0.033.91%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 237.26M | 148.20M | 80.72M | 47.40M | 28.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 237.26M | 148.20M | 80.72M | 47.40M | 28.70M |
| Cost of Revenue | 201.58M | 179.08M | 118.20M | 85.94M | 74.21M |
| Gross Profit | 35.68M | -30.88M | -37.48M | -38.55M | -45.51M |
| SG&A Expenses | 17.61M | 17.97M | 18.03M | 18.61M | 20.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 219.18M | 197.05M | 136.23M | 104.55M | 94.99M |
| Operating Income | 18.07M | -48.84M | -55.51M | -57.16M | -66.29M |
| Income Before Tax | 16.80M | -50.40M | -56.33M | -57.81M | -66.69M |
| Income Tax Expenses | 476.00K | 308.00K | 309.00K | 310.00K | 260.00K |
| Earnings from Continuing Operations | 16.33 | -50.70 | -56.64 | -58.12 | -66.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.33M | -50.70M | -56.64M | -58.12M | -66.95M |
| EBIT | 18.07M | -48.84M | -55.51M | -57.16M | -66.29M |
| EBITDA | 26.65M | -40.08M | -46.60M | -48.24M | -57.44M |
| EPS Basic | 0.06 | -0.22 | -0.25 | -0.27 | -0.35 |
| Normalized Basic EPS | 0.04 | -0.14 | -0.15 | -0.17 | -0.22 |
| EPS Diluted | 0.06 | -0.22 | -0.25 | -0.27 | -0.35 |
| Normalized Diluted EPS | 0.04 | -0.14 | -0.15 | -0.17 | -0.22 |
| Average Basic Shares Outstanding | 921.08M | 912.80M | 911.33M | 867.66M | 808.55M |
| Average Diluted Shares Outstanding | 921.38M | 912.80M | 911.33M | 867.66M | 808.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |